We describe a two-site, sandwich methodology for human albumin in urine. In the assay, albumin binds to a solid-phase monoclonal antibody and to another monoclonal that is biotinylated. The immunocomplex is then quantified by adding streptavidin which is labelled with an europium chelator, using time-resolved fluorometry. The assay is extremely sensitive (< 1 µg/L) and specific. A sample predilution of 251-fold or more is needed before analysis. The analytical parameters studied (precision, recovery, linearity, comparisons) were found to be satisfactory. The assay is simple to perform and is proposed as a non-isotopic alternative to radioimmunoassay for the quantification of small amounts of albumin in urine for the purpose of assessing microalbuminuria.
VibertiGCJarrettRJMahmudUHillRDArgyropoulosAKeenH.Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet1982; i: 1430–2.
2.
MogensenCE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med1984: 310: 356–60.
3.
MogensenCE. Urinary albumin excretion in early and long-term juvenile diabetes. Scand J Clin Lab Invest1971; 28: 183–93.
4.
VibertiGCPickupJCJarrettRJKeenH.Effect of control of blood glucose on urinary excretion of albumin and β2-microglobulin in insulin-dependent diabetes. N Engl J Med1979; 300: 638–41.
5.
ParvingHHOxenbollBSvendsenPAChristiansenJSAndersenAR. Early detection of patients at risk of developing diabetic nephropathy: A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh)1982; 100: 550–5.
6.
MogensenCEChristensenCK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med1984; 311: 89–93.
7.
MathiesenEROxenbollBJohansenKSvendsenPADeckertT.Incipient nephropathy in type I (insulin-dependent) diabetes. Diabetologia1984; 26: 406–10.
8.
ChaversBMBilousRWEllisENSteffesMWMauerMS. Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med1989; 320: 966–70.
9.
Feldt-RasmussenBMathiesenERDeckertT.Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet1986; ii: 1300–4.
10.
VibertiGKeenH.The patterns of proteinuria in diabetes mellitus. Diabetes1984; 33: 686–92.
11.
ColwellMHalseyJF. High incidence of false-positive albuminuria results with the Micro-Bumintest™. Clin Chem1989; 35: 252.
12.
KeenHChlouverakisC.An immunoassay method for urinary albumin at low concentrations. Lancet1963; ii: 913–4.
13.
MilesDWMogensenCEGundersenHJ. Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest1970; 26: 5–11.
14.
ChaversBMSimonsonJMichaelAF. A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int1984; 25: 576–8.
15.
DiamandisEP. Immunoassays with time-resolved fluorescence spectroscopy. Principles and applications. Clin Biochem1988; 21: 139–50.
16.
DiamandisEPMortonRC. Time-resolved fluorescence using a europium chelate of 4,7-bis (chlorosulfophenyl)-1, 10 phenanthroline-2,9-dicarboxylic acid (BCPDA). Labelling procedures and applications in immunoassays. J Immunol Methods1988; 112: 43–52.
17.
DiamandisEPMortonRCReichsteinEKhosraviMJ. Multiple fluorescence labelling with europium chelators. Application to time-resolved fluoroimmunoassays. Anal Chem1989; 61: 48–53.
18.
EvangelistaRAPollakAAlloreBTempletonEFMortonRCDiamandisEP. A new europium chelate for protein labelling and time-resolved fluorometric applications. Clin Biochem1988; 21: 173–8.
19.
KhosraviMJDiamandisEP. Immunofluorometry of choriogonadotropin by time-resolved fluorescence spectroscopy, with a new europium chelate as label. Clin Chem1987; 33: 1994–9.
20.
HoweyJEABrowningMCFraserCG. Selecting the optimum specimen for assessing slight albuminuria, and a strategy for clinical investigation: Novel uses of data on biological variation. Clin Chem1987; 33: 2034–8.
21.
HutchinsonASO'ReillyDMacCuishAC. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem1988; 34: 2019–21.
22.
WallerKVWardKMMahanJDWismattDK. Current concepts in proteinuria. Clin Chem1989; 35: 755–65.
23.
EkinsRP: Current concepts and future development. In: CollinsWP ed. Alternative Immunoassays. New York: John Wiley & Sons1985; 219–37.
